Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 22, 2020Scientific ReportsOpen Access

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis

View Full Paper
Ask AI
Bookmark
Share

Authors

SPShabi ParvezGYGanesh YadagiriMGMallikarjuna Rao Gedda

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Parvez et al. (2020) studied this question.

synapsesocial.com/papers/6a79abc277336a1bae026dffhttps://doi.org/10.1038/s41598-020-69276-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Visceral leishmaniasis2015 · 22 citations
  2. 2Innovations for the elimination and control of visceral leishmaniasis2019 · 54 citations
  3. 3Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis2017 · 119 citations
  4. 4Drug resistance in leishmaniasis: Newer developments2014 · 152 citations
  5. 5New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine2008 · 212 citations